CLBT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cellebrite DI Ltd (CLBT) is not a strong buy at this moment for a long-term beginner investor with $50,000-$100,000 available for investment. While the company shows solid financial growth and positive analyst sentiment, the technical indicators and options data suggest a neutral to slightly bearish short-term trend. Additionally, there are no significant trading signals or recent influential catalysts to justify immediate action.
The technical indicators are mixed to bearish. The MACD histogram is negative (-0.111) and contracting, RSI is neutral at 49.426, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 12.867, with key resistance at 14.303 and support at 11.43.
Cellebrite's recent Digital Justice Awards event showcased its global influence and innovation in digital forensics. The company also demonstrated strong community responsibility through charitable donations. Financially, the company reported strong Q4 results with 18.13% YoY revenue growth and 21% ARR growth.
Technical indicators suggest a lack of upward momentum. Analysts have lowered price targets despite maintaining Buy ratings, citing market contraction. Options data indicates higher put volume relative to calls, suggesting bearish sentiment.
In Q4 2025, Cellebrite reported revenue growth of 18.13% YoY to $128.82M, net income growth of 7.68% YoY to $20.75M, and gross margin improvement to 84.71%. However, EPS remained flat YoY at 0.08.
Analysts maintain Buy ratings but have lowered price targets (e.g., Needham: $18, TD Cowen: $23, Lake Street: $21) due to market contraction. Analysts highlight strong ARR growth and solid 2026 guidance but express caution about profitability and revenue distribution.
